Published in Med Clin (Barc) on July 31, 2011
Heart failure in primary care: co-morbidity and utilization of health care resources. Fam Pract (2013) 0.82
Multimorbidity patterns in primary care: interactions among chronic diseases using factor analysis. PLoS One (2012) 1.71
Antimuscarinic persistence patterns in newly treated patients with overactive bladder: a retrospective comparative analysis. Int Urogynecol J (2013) 1.57
Comorbidity of dementia: a cross-sectional study of primary care older patients. BMC Psychiatry (2014) 1.20
Multimorbidity, polypharmacy, referrals, and adverse drug events: are we doing things well? Br J Gen Pract (2012) 1.17
The Ariadne principles: how to handle multimorbidity in primary care consultations. BMC Med (2014) 1.13
Age and gender differences in the prevalence and patterns of multimorbidity in the older population. BMC Geriatr (2014) 1.02
Primary care utilisation patterns among an urban immigrant population in the Spanish National Health System. BMC Public Health (2011) 1.02
Frequent attenders in general practice and immigrant status in Norway: a nationwide cross-sectional study. Scand J Prim Health Care (2014) 1.00
Applying diagnosis and pharmacy-based risk models to predict pharmacy use in Aragon, Spain: the impact of a local calibration. BMC Health Serv Res (2010) 0.99
Metabolic syndrome in outpatients receiving antipsychotic therapy in routine clinical practice: a cross-sectional assessment of a primary health care database. Eur Psychiatry (2007) 0.95
Adjusted Clinical Groups use as a measure of the referrals efficiency from primary care to specialized in Spain. Eur J Public Health (2007) 0.92
[Impact of morbidity, resource use and costs on maintenance of remission of major depression in Spain: a longitudinal study in a population setting]. Gac Sanit (2009) 0.89
Underreporting of recognized adverse drug reactions by primary care physicians: an exploratory study. Pharmacoepidemiol Drug Saf (2011) 0.89
[Consumption of oral analgesics and dosage forms in elderly patients: population-based study]. Farm Hosp (2009) 0.87
Comparison of escitalopram vs. citalopram and venlafaxine in the treatment of major depression in Spain: clinical and economic consequences. Curr Med Res Opin (2010) 0.85
[Validating the Adjusted Clinical Groups [ACG] case-mix system in a Spanish population setting: a multicenter study]. Gac Sanit (2009) 0.85
The influence of obesity and overweight on medical costs: a panel data perspective. Eur J Health Econ (2014) 0.85
[Use of resources and costs profile in patients with fibromyalgia or generalized anxiety disorder in primary care settings]. Aten Primaria (2009) 0.83
Association between physical activity, multimorbidity, self-rated health and functional limitation in the Spanish population. BMC Public Health (2014) 0.83
The relationship between effectiveness and costs measured by a risk-adjusted case-mix system: multicentre study of Catalonian population data bases. BMC Public Health (2009) 0.82
Obtaining the mean relative weights of the cost of care in Catalonia (Spain): retrospective application of the adjusted clinical groups case-mix system in primary health care. J Eval Clin Pract (2012) 0.82
Retrospective epidemiological study for the characterization of community- acquired pneumonia and pneumococcal pneumonia in adults in a well-defined area of Badalona (Barcelona, Spain). BMC Infect Dis (2012) 0.82
[Comparison of three methods for measuring multiple morbidity according to the use of health resources in primary healthcare]. Aten Primaria (2011) 0.82
[Prospects of adjusted clinical groups (ACG's) in capitated payment risk adjustment]. Rev Esp Salud Publica (2006) 0.82
[Primary care doctors' opinion on a risk adjustment system: adjusted clinical groups]. Rev Peru Med Exp Salud Publica (2013) 0.81
Impact of negative symptoms on healthcare resource utilization and associated costs in adult outpatients with schizophrenia: a population-based study. BMC Psychiatry (2014) 0.80
[Incidence, resource use and costs associated with postherpetic neuralgia: a population-based retrospective study]. Rev Neurol (2012) 0.79
Cost analysis of adding pregabalin or gabapentin to the management of community-treated patients with peripheral neuropathic pain. J Eval Clin Pract (2011) 0.79
Does the pharmacy expenditure of patients always correspond with their morbidity burden? Exploring new approaches in the interpretation of pharmacy expenditure. BMC Public Health (2010) 0.79
[Distribution of primary care expenditure according to sex and age group: a retrospective analysis]. Aten Primaria (2011) 0.78
Physicians' and patients' opinions on the use of generic drugs. J Pharmacol Pharmacother (2012) 0.77
[Relationship among the degree of control of arterial hypertension, comorbidity and costs in individuals over age 30 during 2006]. Rev Esp Salud Publica (2008) 0.77
[Clinical and economic evaluation in accordance with the level of cardiovascular risk in subjects appertaining to Spanish population setting]. Med Clin (Barc) (2008) 0.77
Health economics perspective of fesoterodine, tolterodine or solifenacin as first-time therapy for overactive bladder syndrome in the primary care setting in Spain. BMC Urol (2013) 0.77
Pharmacoeconomic outcomes for pregabalin: a systematic review in neuropathic pain, generalized anxiety disorder, and epilepsy from a Spanish perspective. Adv Ther (2014) 0.77
[Cost of arterial hypertension according to levels of morbidity in primary care setting]. Med Clin (Barc) (2009) 0.77
Effect of smoking status on healthcare costs and resource utilization in patients with type 2 diabetes in routine clinical practice: a retrospective nested case-control economic study. Eur Addict Res (2013) 0.77
Assessment of pharmacological strategies for management of major depressive disorder and their costs after an inadequate response to first-line antidepressant treatment in primary care. Ann Gen Psychiatry (2012) 0.77
[Adjusted clinical groups use at a Spanish primary care center: a retrospective, population-based study]. Rev Panam Salud Publica (2010) 0.77
[Adjusted clinicals groups: a patient classification system through risk adjustment]. Rev Peru Med Exp Salud Publica (2013) 0.76
[Influence of morbidity and the use of health resources in patients who require care for generalised anxiety disorder in the primary health care setting]. Aten Primaria (2008) 0.76
Resource use and economic impact of patients with gout: a multicenter, population-wide study. Reumatol Clin (2013) 0.76
[Costs and associated factors with optimal and suboptimal responses to the treatment of major depressive disorder]. Aten Primaria (2012) 0.76
Adaptive capacity of the Adjusted Clinical Groups Case-Mix System to the cost of primary healthcare in Catalonia (Spain): a observational study. BMJ Open (2012) 0.76
Healthcare costs of the combination of metformin/dipeptidyl peptidase-4 inhibitors compared with metformin/other oral antidiabetes agents in patients with type 2 diabetes and metabolic syndrome. Diabetes Technol Ther (2014) 0.76
Cost and clinical consequences of smoking cessation in outpatients after cardiovascular disease: a retrospective cohort study. Clinicoecon Outcomes Res (2013) 0.75
[Association and control of cardiovascular risk factors in the primary health-care setting]. Med Clin (Barc) (2005) 0.75
Relationship between efficiency and clinical effectiveness indicators in an adjusted model of resource consumption: a cross-sectional study. BMC Health Serv Res (2013) 0.75
Pharmaceutical cost control in primary care: opinion and contributions by healthcare professionals. BMC Health Serv Res (2009) 0.75
Healthcare use and costs associated with obesity in Badalona, Spain: a study protocol. BMJ Open (2012) 0.75
Use of aspirin for primary and secondary prevention of cardiovascular disease in diabetic patients in an ambulatory care setting in Spain. BMC Fam Pract (2007) 0.75
Relationship between obesity and antipsychotic drug use in the adult population: a longitudinal, retrospective claim database study in Primary Care settings. Neuropsychiatr Dis Treat (2008) 0.75
Clinical validity of a population database definition of remission in patients with major depression. BMC Public Health (2010) 0.75
[Evolution of inappropriate intake of psychoactive drugs in inpatients]. Med Clin (Barc) (2006) 0.75
[Prevalence and economic impact of obesity in adults during 2003-2010]. Med Clin (Barc) (2012) 0.75
[Frequency of attending primary care clinics by the immigrant versus autochthonous population]. Aten Primaria (2011) 0.75
[Calculation of morbidity, use of resources and costs of patients treated with tiotropium bromide for COPD in a Spanish population]. Aten Primaria (2007) 0.75
[All-cause mortality and incidence of major cardiovascular events in hypertensive patients with ASCOT-type profile in a Spanish population setting]. Aten Primaria (2010) 0.75
Budgetary Impact Analysis of Reimbursement Varenicline for the Smoking-Cessation Treatment in Patients with Cardiovascular Diseases, Chronic Obstructive Pulmonary Disease or Type-2 Diabetes Mellitus: A National Health System Perspective. Eur Addict Res (2016) 0.75
[Study of patients with gout: clinical features in the last 2 years of monitoring]. Gac Med Mex (2012) 0.75
[Characterization of and costs associated to the profile of patients with type 2 diabetes treated with metformin who are added a second oral antidiabetic drug: a population study]. Endocrinol Nutr (2013) 0.75
[Use of resources and costs associated to fractures in Spanish women]. Rev Peru Med Exp Salud Publica (2012) 0.75
Cost comparison of adding pregabalin or gabapentin for the first time to the therapy of patients with painful axial radiculopathy treated in Spain. Clin Exp Rheumatol (2013) 0.75
[Smoking, asthma and chronic obstructive pulmonary disease in aduts: a too frequent relation]. Med Clin (Barc) (2008) 0.75
Variations in health services utilization by primary care patients. Health Serv Manage Res (2002) 0.75
[Comparative study of the consumption of psychiatric medication in geriatric homes]. Aten Primaria (2008) 0.75
[Clinical and economic estimation of cardiovascular disease in subjects with several cardiovascular risk factors in the primary health care setting]. Med Clin (Barc) (2008) 0.75
[Fixed drug combinations in hypertension: a budget impact analysis for the Spanish Health System on the marketing of a fixed combination of olmesartan/amlodipine]. Aten Primaria (2011) 0.75
[Estimation of chronic co-morbidity on health costs in elderly patients with neurological disorders]. Rev Peru Med Exp Salud Publica (2011) 0.75